The agreement means people with spinal cord injuries in Germany could benefit from use of the ReWalk 6.0 exoskeleton sysyem.

This deal could have a significant impact for spinal cord injured individuals.

Under this agreement, eligible beneficiaries will be able to obtain a ReWalk 6.0 exoskeleton device for use in the home that will enable them to stand and walk again, after successful training and verification by the medical service.

Three SCI beneficiaries have already received access on the back of the news.

In 2018, the ReWalk 6.0 personal exoskeleton system was added to the German National Health Insurance Agency’s National Medical Device Directory, which includes all medical devices that are principally and regularly reimbursed by German Statutory Health Insurance (SHI) providers.

That addition was a critical turning point, enabling any of Germany’s 105 SHIs to pursue national policies for ReWalk procurement.

ReWalk CEO Larry Jasinski said: “This is the first in a series of contracts with German insurers that will benefit paralysed individuals nationwide.

“These policies, which have been in development since our addition to the MDD, will make the procurement process predictable for patients; after successful training and approval for procurement by the insurer, patients will be able to take home a device for daily personal use.

“We are so pleased to get these devices to people who need them more quickly and provide access to life-changing technology.”

ReWalk develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.

Founded in 2001, ReWalk has headquarters in the US, Israel and Germany.